Protocol Ledger

NCT03877510 · Phase III · COMPLETED

Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations

Interventional Phase III clinical trial protocol NCT03877510 sponsored by Impax Laboratories in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-04-03 Enrollment: 419 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03877510
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)419 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03877510
Protocol FieldVerified Registry Value
NCT IdentifierNCT03877510
Consolidated Lead SponsorImpax Laboratories
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment419 participants (ACTUAL)
Registered Start Date2019-04-03
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI